Search Results - "Vora, Sujay A"

Technical note: Comprehensive evaluations of gantry and couch rotation isocentricities for implementing proton stereotactic radiosurgery by Shen, Jiajian, Robertson, Daniel G., Bues, Martin, Shipulin, Konstantin, Liu, Wei, Stoker, Joshua, Ashman, Jonathan B., Lara, Pedro, Keole, Sameer R., Wong, William, Vora, Sujay A.

“…Background Mechanical accuracy should be verified before implementing a proton stereotactic radiosurgery (SRS) program. Linear accelerator (Linac)‐based SRS…”
Get full text

Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial by Routman, David M, Jusue-Torres, Ignacio, Brown, Paul D, Trifiletti, Daniel M, Vora, Sujay A, Brown, Desmond A, Parney, Ian F, Burns, Terry C, Yan, Elizabeth

“…Almost one third of cancer patients in the United States will develop brain metastases on an annual basis. Surgical resection is indicated in the setting of…”
Get full text

Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost by Laughlin, Brady S, Silva, Alvin C, Vora, Sujay A, Keole, Sameer R, Wong, William W, Schild, Michael H, Schild, Steven E

“…This retrospective study demonstrates the long-term outcomes of treating prostate cancer using intensity modulated (IMRT) with incorporation of MRI-directed…”
Get full text

Factors Associated with Survival following Radium-223 Treatment for Metastatic Castration- Resistant Prostate Cancer by Wong, William W., M.D, Anderson, Eric M., M.D, Mohammadi, Homan, M.D, Daniels, Thomas B., M.D, Schild, Steve E., M.D, Keole, Sameer R., M.D, Choo, Richard, M.D, Tzou, Katherine S., M.D, Bryce, Alan H., M.D, Ho, Thai H., M.D. PhD, Quevedo, Fernando J., M.D, Vora, Sujay A., M.D

“…Abstract Background Radium-223 improves survival in patients with metastatic castration-resistant prostate cancer (mCRPC). This retrospective analysis was…”
Get full text

Dosimetric advantages of proton beam therapy compared to intensity-modulated radiation therapy for retroperitoneal chordoma by Yu, Nathan Y, Vora, Sujay A

“…Retroperitoneal chordomas are exceedingly rare and account for less than 5% of all primary bone malignancies. Their etiology remains unknown. We report a rare…”
Get full text

Analysis of Biochemical Control and Prognostic Factors in Patients Treated With Either Low-Dose Three-Dimensional Conformal Radiation Therapy or High-Dose Intensity-Modulated Radiotherapy for Localized Prostate Cancer by Vora, Sujay A., M.D, Wong, William W., M.D, Schild, Steven E., M.D, Ezzell, Gary A., Ph.D, Halyard, Michele Y., M.D

“…Purpose: To identify prognostic factors and evaluate biochemical control rates for patients with localized prostate cancer treated with either high-dose…”
Get full text

Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience by Bhangoo, Ronik S., DeWees, Todd A., Yu, Nathan Y., Ding, Julia X., Liu, Chenbin, Golafshar, Michael A., Rule, William G., Vora, Sujay A., Ross, Helen J., Ahn, Daniel H., Beamer, Staci E., Jaroszewski, Dawn E., Hallemeier, Christopher L., Liu, Wei, Ashman, Jonathan B., Sio, Terence T.

“…Intensity modulated proton beam radiation therapy (IMPT) has a clinically significant dosimetric advantage over intensity modulated photon radiation therapy…”
Get full text

Does Zinc Sulfate Prevent Therapy-Induced Taste Alterations in Head and Neck Cancer Patients? Results of Phase III Double-Blind, Placebo-Controlled Trial from the North Central Cancer Treatment Group (N01C4) by Halyard, Michele Y., M.D, Jatoi, Aminah, M.D, Sloan, Jeff A., Ph.D, Bearden, James D., M.D, Vora, Sujay A., M.D, Atherton, Pamela J., M.S, Perez, Edith A., M.D, Soori, Gammi, M.D, Zalduendo, Anthony C., M.D, Zhu, Angela, M.D, Stella, Philip J., M.D, Loprinzi, Charles L., M.D

“…Purpose: Taste alterations (dysgeusia) are well described in head and neck cancer patients who undergo radiotherapy (RT). Anecdotal observations and pilot…”
Get full text

Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma by Thomson, Holly M, Fortin Ensign, Shannon P, Edmonds, Victoria S, Sharma, Akanksha, Butterfield, Richard J, Schild, Steven E, Ashman, Jonathan B, Zimmerman, Richard S, Patel, Naresh P, Bryce, Alan H, Vora, Sujay A, Sio, Terence T, Porter, Alyx B

“…Background: Radiation necrosis (RN) is a clinically relevant complication of stereotactic radiosurgery (SRS) for intracranial metastasis (ICM) treatments…”
Get full text

Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer by Anderson, Justin D, Voss, Molly M, Laughlin, Brady S, Garda, Allison E, Aziz, Khaled, Mullikin, Trey C, Haddock, Michael G, Petersen, Ivy A, DeWees, Todd A, Vora, Sujay A

“…To compare Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in patients with endometrial cancer receiving…”
Get full text

Comprehensive Commissioning and Clinical Implementation of GammaTiles STaRT for Intracranial Brain Cancer by Penoncello, Gregory P., Gagneur, Justin D., Vora, Sujay A., Yu, Nathan Y., Fatyga, Mirek, Mrugala, Maciej M., Bendok, Bernard R., Rong, Yi

“…To validate the dose calculation accuracy and dose distribution of GammaTiles for brain tumors, and to suggest a surgically targeted radiation therapy (STaRT)…”
Get full text

Image-Guided Radiotherapy for Prostate Cancer: A Prospective Trial of Concomitant Boost Using Indium-111–Capromab Pendetide (ProstaScint) Imaging by Wong, William W., M.D, Schild, Steven E., M.D, Vora, Sujay A., M.D, Ezzell, Gary A., Ph.D, Nguyen, Ba D., M.D, Ram, Panol C., M.D, Roarke, Michael C., M.D

“…Purpose To evaluate, in a prospective study, the use of111 In–capromab pendetide (ProstaScint) scan to guide the delivery of a concomitant boost to…”
Get full text

Management and outcomes of primary vaginal Cancer by Yang, Jie, Delara, Ritchie, Magrina, Javier, Magtibay, Paul, Langstraat, Carrie, Dinh, Tri, Karlin, Nina, Vora, Sujay A., Butler, Kristina

“…To analyze clinical characteristics and survival of patients with primary vaginal cancer. Retrospective analysis of patients with primary squamous,…”
Get full text

Analysis of MRI Volumetric Changes After Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial Neoplasms by Fega, Kathryn R., MD, PhD, Fletcher, Geoffrey P., MD, Waddle, Mark R., MD, Peterson, Jennifer L., MD, Ashman, Jonathan B., MD, PhD, Barrs, David M., MD, Bendok, Bernard R., MD, Patel, Naresh P., MD, Porter, Alyx B., MD, Vora, Sujay A., MD

“…Abstract Purpose To quantitatively assess volumetric changes after hypofractionated stereotactic radiation therapy (HFSRT) in patients treated for vestibular…”
Get full text

Technical note: Generalizable and promptable artificial intelligence model to augment clinical delineation in radiation oncology by Zhang, Lian, Liu, Zhengliang, Zhang, Lu, Wu, Zihao, Yu, Xiaowei, Holmes, Jason, Feng, Hongying, Dai, Haixing, Li, Xiang, Li, Quanzheng, Wong, William W., Vora, Sujay A., Zhu, Dajiang, Liu, Tianming, Liu, Wei

“…Background Efficient and accurate delineation of organs at risk (OARs) is a critical procedure for treatment planning and dose evaluation. Deep learning‐based…”
Get full text

Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience by Hobbs, Corey J., Ko, Stephen J., Paryani, Nitesh N., Accurso, Joseph M., Olivier, Kenneth R., Garces, Yolanda I., Park, Sean S., Hallemeier, Christopher L., Schild, Steven E., Vora, Sujay A., Ashman, Jonathan B., Rule, William G., Bowers, Johnny R., Heckman, Michael G., Diehl, Nancy N., Miller, Robert C.

“…To examine disease control and survival after stereotactic body radiotherapy (SBRT) for medically inoperable, early-stage non–small cell lung cancer (NSCLC)…”
Get full text

Robust Optimization for Spot Scanning Proton Therapy based on Dose-Linear Energy Transfer (LET) Volume Constraints by Chen, Jingyuan, Yang, Yunze, Feng, Hongying, Zhang, Lian, Liu, Zhengliang, Liu, Tianming, Vargas, Carlos E., Yu, Nathan Y., Rwigema, Jean-Claude M., Keole, Sameer R., Patel, Samir H., Vora, Sujay A., Shen, Jiajian, Liu, Wei

“…Historically, spot scanning proton therapy (SSPT) treatment planning utilizes dose volume constraints and linear-energy-transfer (LET) volume constraints…”
Get full text

Online Adaptive Proton Therapy Facilitated by Artificial Intelligence–Based Autosegmentation in Pencil Beam Scanning Proton Therapy by Feng, Hongying, Shan, Jie, Vargas, Carlos E., Keole, Sameer R., Rwigema, Jean-Claude M., Yu, Nathan Y., Ding, Yuzhen, Zhang, Lian, Hu, Yanle, Schild, Steven E., Wong, William W., Vora, Sujay A., Shen, JiaJian, Liu, Wei

“…Online adaptive proton therapy (oAPT) is essential to address interfractional anatomical changes in patients receiving pencil beam scanning proton therapy…”
Get full text

Beam mask and sliding window‐facilitated deep learning‐based accurate and efficient dose prediction for pencil beam scanning proton therapy by Zhang, Lian, Holmes, Jason M., Liu, Zhengliang, Vora, Sujay A., Sio, Terence T., Vargas, Carlos E., Yu, Nathan Y., Keole, Sameer R., Schild, Steven E., Bues, Martin, Li, Sheng, Liu, Tianming, Shen, Jiajian, Wong, William W., Liu, Wei

“…Background Accurate and efficient dose calculation is essential for on‐line adaptive planning in proton therapy. Deep learning (DL) has shown promising dose…”
Get full text

A deep learning model for discriminating true progression from pseudoprogression in glioblastoma patients by Moassefi, Mana, Faghani, Shahriar, Conte, Gian Marco, Kowalchuk, Roman O., Vahdati, Sanaz, Crompton, David J., Perez-Vega, Carlos, Cabreja, Ricardo A. Domingo, Vora, Sujay A., Quiñones-Hinojosa, Alfredo, Parney, Ian F., Trifiletti, Daniel M., Erickson, Bradley J.

“…Introduction Glioblastomas (GBMs) are highly aggressive tumors. A common clinical challenge after standard of care treatment is differentiating tumor…”
Get full text